Bi-Allelic MARVELD2 Variant Identified with Exome Sequencing in a Consanguineous Multiplex Ghanaian Family Segregating Non-Syndromic Hearing Loss
Authors:
- Elvis Twumasi AboagyeElvis Twumasi Aboagye
- Samuel Mawuli AdadeySamuel Mawuli Adadey
- Leonardo Alves de Souza RiosLeonardo Alves de Souza Rios
- Kevin K. EsohKevin K. Esoh
- Edmond Wonkam-TingangEdmond Wonkam-Tingang
- Lettilia XhakazaLettilia Xhakaza
- Carmen De KockCarmen De Kock
- Isabelle SchrauwenIsabelle Schrauwen
- Lucas Amenga-EtegoLucas Amenga-Etego
- Dirk LangDirk Lang
- Gordon A. AwandareGordon A. Awandare
- Suzanne M. LealSuzanne M. Leal
Open Access
- 3 April 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (7) , 3337
Abstract
Genetic studies and phenotypic expansion of hearing loss (HL) for people living in Africa are greatly needed. We evaluated the clinical phenotypes of three affected siblings presenting non-syndromic (NS) HL and five unaffected members of a consanguineous Ghanaian family. Analysis of exome sequence data was performed for all affected and one unaffected family members. In-depth genetic and cellular characterization studies were performed to investigate biological significance of the implicated variant using bioinformatic tools and cell-based experimentation. Audiological examinations showed severe-to-profound, bilateral, symmetrical, and post-lingual onset. The whole-exome sequencing (WES) identified a homozygous frameshift variant: MARVEL domain containing 2 (MARVELD2):c.1058dup;p.(Val354Serfs*5) in all affected siblings. This frameshift variant leads to an early stop codon insertion and predicted to be targeted by nonsense medicated decay (mutant protein predicted to lack conserved C-terminal domain if translated). Cell immunofluorescence and immunocytochemistry studies exposed the functional impact of the mutant protein’s expression, stability, localization, protein–protein binding, barrier function, and actin cytoskeleton architecture. The identified variant segregates with NSHL in the index Ghanaian family. The data support this nonsense variant as pathogenic, likely to impact the homeostasis of ions, solutes, and other molecules, compromising membrane barrier and signaling in the inner ear spaces.Keywords
Funding Information
- National Institutes of Health (NIH) (U01-HG-009716, DC003594, H3A/18/001)
- African Academy of Science/Wellcome Trust (U01-HG-009716, DC003594, H3A/18/001)
- WACCBIP-World Bank African Centre of Excellence PhD fellowship (WACCBIP+NCDs) (U01-HG-009716, DC003594, H3A/18/001)
This publication has 53 references indexed in Scilit:
- Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteriaThe American Journal of Human Genetics, 2022
- The Impact of Hearing Loss and Its Treatment on Health-Related Quality of Life Utility: a Systematic Review with Meta-analysisJournal of General Internal Medicine, 2022
- Hearing loss in Africa: current genetic profileHuman Genetics, 2021
- Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing lossHuman Mutation, 2018
- Genomic Landscape and Mutational Signatures of Deafness-Associated GenesThe American Journal of Human Genetics, 2018
- The impact of rehabilitation on quality of life after hearing loss: a systematic reviewEuropean Archives of Oto-Rhino-Laryngology, 2018
- Genetics of Hearing and DeafnessThe Anatomical Record, 2012
- A comprehensive study to determine heterogeneity of autosomal recessive nonsyndromic hearing loss in IranAmerican Journal of Medical Genetics Part A, 2012
- Splice-site mutations in the TRIC gene underlie autosomal recessive nonsyndromic hearing impairment in Pakistani familiesJournal of Human Genetics, 2007
- A new locus for nonsyndromic deafness DFNB49 maps to chromosome 5q12.3-q14.1Human Genetics, 2004